Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-014413
Filing Date
2012-03-05
Accepted
2012-03-05 18:43:04
Documents
1
Period of Report
2012-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd336973.html 4  
1 FORM 4 rrd336973.xml 4 4102
  Complete submission text file 0001181431-12-014413.txt   5459
Mailing Address C/O PHARMION CORP 2525 28TH ST BOULDER CO 80301
Business Address
MAHAFFY PATRICK J (Reporting) CIK: 0001266569 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 12668165

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations